• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ivermectin as a multifaceted drug in COVID-19: Current insights.

作者信息

Khandelwal Ankur, Singh Gyaninder Pal, Jamil Shaista

机构信息

Assistant Professor (Anaesthesiology) & Critical Care, Sharda University School of Medical Sciences & Research, Greater Noida, UP India.

Additional Professor (Neuroanaesthesiology) & Critical Care, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

出版信息

Med J Armed Forces India. 2021 Jul;77(Suppl 2):S254-S256. doi: 10.1016/j.mjafi.2021.06.002. Epub 2021 Jul 26.

DOI:10.1016/j.mjafi.2021.06.002
PMID:34334890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8313054/
Abstract
摘要

相似文献

1
Ivermectin as a multifaceted drug in COVID-19: Current insights.
Med J Armed Forces India. 2021 Jul;77(Suppl 2):S254-S256. doi: 10.1016/j.mjafi.2021.06.002. Epub 2021 Jul 26.
2
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验（SAINT）评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力：一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
3
Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.随机临床试验比较伊维菌素与安慰剂对秘鲁早期 COVID-19 患者鼻咽 PCR 转阴的疗效（SAINT-Peru）：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 9;22(1):262. doi: 10.1186/s13063-021-05236-2.
4
Ivermectin for preventing and treating COVID-19.伊维菌素预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3.
5
Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.定量蛋白质组学揭示了伊维菌素的广谱抗病毒特性，有利于 COVID-19 的治疗。
J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
6
Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.伊维菌素对 SARS-CoV-2 感染的临床和免疫结果的衰减作用。
EMBO Mol Med. 2021 Aug 9;13(8):e14122. doi: 10.15252/emmm.202114122. Epub 2021 Jul 12.
7
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).大剂量伊维菌素治疗早期 COVID-19 的药物代谢动力学：一项开放标签、随机、对照、自适应平台试验（PLATCOV）。
Elife. 2023 Feb 21;12:e83201. doi: 10.7554/eLife.83201.
8
Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model.伊维菌素的预防性给药可减轻叙利亚仓鼠模型中 SARS-CoV-2 诱导的疾病。
J Antibiot (Tokyo). 2023 Aug;76(8):481-488. doi: 10.1038/s41429-023-00623-0. Epub 2023 Apr 25.
9
The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 - a double-blind, randomized placebo-controlled trial.伊维菌素对非住院轻中度 COVID-19 患者早期治疗中病毒载量和培养活力的影响：一项双盲、随机、安慰剂对照试验。
Int J Infect Dis. 2022 Sep;122:733-740. doi: 10.1016/j.ijid.2022.07.003. Epub 2022 Jul 8.
10
Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.单剂量口服伊维菌素治疗轻中度 COVID-19（RIVET-COV）：一项单中心随机、安慰剂对照试验。
J Infect Chemother. 2021 Dec;27(12):1743-1749. doi: 10.1016/j.jiac.2021.08.021. Epub 2021 Aug 25.

引用本文的文献

1
Antiviral Chemotherapy in Avian Medicine-A Review.禽医学中的抗病毒化疗——综述
Viruses. 2024 Apr 12;16(4):593. doi: 10.3390/v16040593.
2
The Role of Cyclodextrins in COVID-19 Therapy-A Literature Review.环糊精在 COVID-19 治疗中的作用——文献综述。
Int J Mol Sci. 2023 Feb 3;24(3):2974. doi: 10.3390/ijms24032974.

本文引用的文献

1
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.综述表明伊维菌素在 COVID-19 预防和治疗中的疗效的新证据。
Am J Ther. 2021 Apr 22;28(3):e299-e318. doi: 10.1097/MJT.0000000000001377.
2
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19.关于伊维菌素治疗新冠肺炎的误导性临床证据和系统评价。
BMJ Evid Based Med. 2022 Jun;27(3):156-158. doi: 10.1136/bmjebm-2021-111678. Epub 2021 Apr 22.
3
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
4
Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis.伊维菌素作为 COVID-19 附加治疗的治疗潜力：系统评价和荟萃分析。
J Pharm Pharm Sci. 2020;23:462-469. doi: 10.18433/jpps31457.
5
Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats.雾化伊维菌素治疗 COVID-19 和其他呼吸道疾病：一项在大鼠中验证概念和剂量范围的研究。
Sci Rep. 2020 Oct 13;10(1):17073. doi: 10.1038/s41598-020-74084-y.
6
White paper on Ivermectin as a potential therapy for COVID-19.关于伊维菌素作为新冠病毒潜在疗法的白皮书。
Indian J Tuberc. 2020 Jul;67(3):448-451. doi: 10.1016/j.ijtb.2020.07.031.
7
Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic.由于新型冠状病毒肺炎大流行而居家隔离期间疥疮的暴发。
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e781-e783. doi: 10.1111/jdv.16879. Epub 2020 Sep 10.
8
Emergency accesses in Dermatology Department during the Covid-19 pandemic in a referral third level center in the north of Italy.意大利北部一家三级转诊中心在新冠疫情期间皮肤科急诊就诊情况。
Dermatol Ther. 2020 Nov;33(6):e14027. doi: 10.1111/dth.14027. Epub 2020 Sep 2.
9
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
10
COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution.新冠疫情与自行服用伊维菌素进行自我治疗和自我给药的热潮：一句警示之言。
One Health. 2020 Jun 24;10:100148. doi: 10.1016/j.onehlt.2020.100148. eCollection 2020 Dec.